Samalin Investment Counsel LLC Grows Holdings in Healthpeak Properties, Inc. $DOC

Samalin Investment Counsel LLC grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 16.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 41,016 shares of the real estate investment trust’s stock after purchasing an additional 5,893 shares during the period. Samalin Investment Counsel LLC’s holdings in Healthpeak Properties were worth $718,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. TCTC Holdings LLC lifted its stake in shares of Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 751 shares during the period. Brooklyn Investment Group raised its holdings in Healthpeak Properties by 198.9% in the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 873 shares during the last quarter. Dagco Inc. purchased a new position in shares of Healthpeak Properties during the 1st quarter worth $30,000. AlphaQuest LLC acquired a new stake in shares of Healthpeak Properties during the second quarter worth $34,000. Finally, Atlantic Union Bankshares Corp acquired a new stake in shares of Healthpeak Properties during the second quarter worth $34,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $17.82 on Monday. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.05. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.28. The company has a market capitalization of $12.38 billion, a price-to-earnings ratio of -356.23, a price-to-earnings-growth ratio of 3.84 and a beta of 1.10. The firm’s fifty day moving average price is $18.38 and its 200 day moving average price is $17.85.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative return on equity of 0.44% and a negative net margin of 1.36%.The company had revenue of $705.87 million during the quarter, compared to analysts’ expectations of $681.65 million. During the same period in the prior year, the business posted $0.45 EPS. The business’s revenue was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 6.8%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio (DPR) is presently -2,440.00%.

Analysts Set New Price Targets

Several analysts have commented on DOC shares. Evercore ISI set a $22.00 price target on Healthpeak Properties in a report on Monday, September 15th. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the company an “outperform” rating in a report on Wednesday, July 30th. Wells Fargo & Company cut their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 27th. Scotiabank cut shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and lowered their price objective for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Finally, Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Monday, September 15th. Seven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $20.91.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.